MCID: HV1005
MIFTS: 30

Hiv-1 Viremia malady

Summaries for Hiv-1 Viremia

About this section
Sources:
48OMIM, 34MalaCards
See all sources

Fully expand this MalaCard

Download this MalaCard
MalaCards: Hiv-1 Viremia, also known as hiv infections, is related to hiv-1 and retinitis. An important gene associated with Hiv-1 Viremia is HLA-C (major histocompatibility complex, class I, C), and among its related pathways are Viral carcinogenesis and HTLV-I infection. The drugs aldesleukin and human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc] and the compounds butyric acid and carbamazepine have been mentioned in the context of this disorder. Affiliated tissues include t cells.

Description from OMIM:48 609423

Aliases & Classifications for Hiv-1 Viremia

About this section
Sources:
48OMIM, 63UMLS
See all sources

Aliases & Descriptions:

hiv-1 viremia 48
hiv infections 63


Related Diseases for Hiv-1 Viremia

About this section
Sources:
18GeneCards, 19GeneDecks
See all sources

Graphical network of the top 20 diseases related to Hiv-1 Viremia:



Diseases related to hiv-1 viremia

Symptoms for Hiv-1 Viremia

About this section
Sources:
48OMIM
See all sources


Clinical features from OMIM:

609423

Drugs & Therapeutics for Hiv-1 Viremia

About this section
Sources:
6CenterWatch, 43NIH Clinical Center, 7ClinicalTrials, 63UMLS, 42NDF-RT
See all sources

Genetic Tests for Hiv-1 Viremia

About this section

Anatomical Context for Hiv-1 Viremia

About this section
Sources:
34MalaCards
See all sources

MalaCards organs/tissues related to Hiv-1 Viremia:

34
T cells

Animal Models for Hiv-1 Viremia or affiliated genes

About this section

Publications for Hiv-1 Viremia

About this section
Sources:
53PubMed
See all sources

Articles related to Hiv-1 Viremia:

(show all 24)
idTitleAuthorsYear
1
Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia. (24361679)
2014
2
Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain. (23723714)
2013
3
Absence of detectable HIV-1 viremia after treatment cessation in an infant. (24152233)
2013
4
Intermittent HIV-1 viremia (blips) and virological failure in a cohort of people living with HIV from SALo Paulo, Brazil. (22916841)
2012
5
Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells. (21367910)
2011
6
High clade C HIV-1 viremia: how did we get here and where are we going? (21747235)
2011
7
Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. (19910789)
2010
8
Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection. (20186346)
2010
9
Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouse. (19494021)
2009
10
The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. (19710502)
2009
11
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. (19470482)
2009
12
Long-term follow-up of patients taking tenofovir DF with low-level HIV-1 viremia and the K65R substitution in HIV-1 RT. (17413698)
2007
13
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. (17376902)
2007
14
HIV-1 viremia during the first 28 weeks of pregnancy is not associated with mother-to-child transmission. (17293908)
2006
15
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection. (16028129)
2005
16
Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. (15713771)
2005
17
HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. (14676302)
2003
18
The -1030/-862-linked TNF promoter single-nucleotide polymorphisms are associated with the inability to control HIV-1 viremia. (14517700)
2003
19
The loss of CMV-specific CD27(-) T-cell effectors in a patient with recurrences of CMV retinitis is independent of HIV-1 viremia. (12382097)
2002
20
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation. (11717444)
2001
21
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. (11309482)
2001
22
Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. (9878015)
1999
23
Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy. (7751690)
1995
24
Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction. (1520538)
1992

Variations for Hiv-1 Viremia

About this section

Expression for genes affiliated with Hiv-1 Viremia

About this section
Sources:
2BioGPS, 16Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Hiv-1 Viremia

Search GEO for disease gene expression data for Hiv-1 Viremia.

Pathways for genes affiliated with Hiv-1 Viremia

About this section
Sources:
51PathCards, 31KEGG, 58SinoBiological, 55R&D Systems, 39NCBI BioSystems Database, 56Reactome, 54QIAGEN, 61Thomson Reuters
See all sources

Compounds for genes affiliated with Hiv-1 Viremia

About this section
Sources:
30IUPHAR, 25HMDB, 46Novoseek, 52PharmGKB, 12DrugBank, 3BitterDB, 62Tocris Bioscience
See all sources

Compounds related to Hiv-1 Viremia according to GeneCards/GeneDecks:

(show all 11)
idCompoundScoreTop Affiliating Genes
1butyric acid30 2510.3TNF, HDAC9
2carbamazepine46 52 1211.3TNF, HDAC9
3chloroquine46 3 52 30 1213.2HDAC9, TNF
4thalidomide46 52 62 1212.2HDAC9, TNF
5mg 13246 6210.2TNF, HDAC9
6tgf beta1469.1HDAC9, TNF
7curcumin469.1TNF, HDAC9
8calcitriol46 62 25 1212.0TNF, HDAC9
9butyrate469.0TNF, HDAC9
10n acetylcysteine468.9HDAC9, TNF
11sb 20358046 629.7TNF, HDAC9

GO Terms for genes affiliated with Hiv-1 Viremia

About this section
Sources:
17Gene Ontology
See all sources

Cellular components related to Hiv-1 Viremia according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1cell surfaceGO:0099868.7MICA, TNF, HLA-C
2integral component of plasma membraneGO:0058877.9SIGLEC7, MICA, TNF, HLA-C

Products for genes affiliated with Hiv-1 Viremia

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Hiv-1 Viremia

About this section
4CDC
14ExPASy
15FMA
23GTR
24HGMD
25HMDB
26ICD10
27ICD10 via Orphanet
28ICD9CM
30IUPHAR
31KEGG
36MeSH
37MESH via Orphanet
38MGI
41NCIt
42NDF-RT
45NINDS
46Novoseek
48OMIM
49OMIM via Orphanet
53PubMed
54QIAGEN
60SNOMED-CT via Orphanet
63UMLS
64UMLS via Orphanet